共 15 条
- [2] MicroRNA-145 Targeted Therapy Reduces Atherosclerosis[J] . Fina Lovren,Yi Pan,Adrian Quan,Krishna K. Singh,Praphulla C. Shukla,Nandini Gupta,Brent M. Steer,Alistair J. Ingram,Milan Gupta,Mohammed Al-Omran,Hwee Teoh,Philip A. Marsden,Subodh Verma.  Circulation . 2012 (11 s)
- [5] Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Rajagopalan Sanjay,Somers Emily C,Brook Robert D,Kehrer Christine,Pfenninger Dana,Lewis Emily,Chakrabarti Anjan,Richardson Bruce C,Shelden Eric,McCune W Joseph,Kaplan Mariana J. Blood . 2004
- [6] Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus. de Leeuw K,Freire B,Smit A J,Bootsma H,Kallenberg C G,Bijl M. Lupus . 2006
- [7] miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Cordes Kimberly R,Sheehy Neil T,White Mark P,Berry Emily C,Morton Sarah U,Muth Alecia N,Lee Ting-Hein,Miano Joseph M,Ivey Kathryn N,Srivastava Deepak. Nature . 2009
- [8] Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Banfi G,Bertani T,Boeri V,Faraggiana T,Mazzucco G,Monga G,Sacchi G. American journal of kidney diseases : the official journal of the National Kidney Foundation . 1991
- [9] [Cardiovascular risk in autoimmune and inflammatory disorders]. Peeters M-A,Chizzolini C. Revue médicale suisse . 2011
- [10] The classification of glomerulonephritis in systemic lupus erythematosus revisited. Weening JJ,D’Agati VD,Schwartz MM,et al. Kidney International . 2004